Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.

Molecular Oncology 2016 June 25 [Epub ahead of print] [Link] Meerang M, Bérard K, Friess M, Bitanihirwe BK, Soltermann A, Vrugt B, Felley-Bosco E, Bueno R, Richards WG, Seifert B, Stahel R, Weder W, Opitz I. Abstract INTRODUCTION: Alterations of the tumor suppressor Neurofibromatosis type II (NF2) have been reported in about 40% of Malignant…

Read More

Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives

Current Oncology 2016 June 23 [Epub June 9] [Link] Spiliotis J, Halkia E, de Bree E. Abstract Peritoneal carcinomatosis (ptc) represents advanced malignant disease and has generally been associated with a grim prognosis. Peritoneal surface malignancy is often the major source of morbidity and mortality; it is of major concern in cancer management. Although ptc…

Read More

Diffuse malignant biphasic peritoneal mesothelioma with cystic areas

Annali italiani di chiurgia 2016 June 20 [Epub ahead of print] [Link] Cabibi D, Tutino R, Salamone G, Cocorullo G, Agrusa A, Gulotta G. Abstract We report a case of peritoneal biphasic mesothelioma with cystic areas in a patient with professional exposure to asbestos. It showed focal epithelial glandular and papillary proliferations, also presenting fluid…

Read More

Simple benchmark for mesothelioma projection for Great Britain

Occupational and Environmental Medicine 2016 May 31 [Epub ahead of print] [Link] Martínez-Miranda MD, Nielsen B, Nielsen JP. Abstract BACKGROUND: It is of considerable interest to forecast the future burden of mesothelioma mortality. Data on deaths are available, whereas no measure of asbestos exposure is available. METHODS: We compare two Poisson models: a response-only model…

Read More

Malignant pleural mesothelioma: initial experience in integrated 18F-FDG PET/MR imaging

Clinical Imaging 2016 May 11 [Epub ahead of print] [Link] Schaarschmidt BM, Sawicki LM, Gomez B, Grueneisen J, Hoiczyk M, Heusch P, Buchbender C. Asbstract PURPOSE: This study aims to compare staging results of 18F-FDG PET/computed tomography (CT) and integrated PET/magnetic resonance (MR) in malignant pleural mesothelioma (MPM) patients and to investigate a potential apparent…

Read More

The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.

Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016 May 12 [Epub ahead of print] [Link] Orgiano L, Pani F, Astara G, Madeddu C, Marini S, Manca A, Mantovani G. Abstract PURPOSE: The purpose of this study was to review the results of a single-center experience in the…

Read More

Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study.

The European Respiratory Journal 2016 May 12 [Epub ahead of print] [Link] Ji J, Sundquist J, Sundquist K. Abstract Familial clustering of pleural mesothelioma was reported previously, but none of the reports quantified the familial risk of mesothelioma or the association with other cancers. The contributions of shared environmental or genetic factors to the aggregation…

Read More